Comment on Bezin et al. GLP-1 Receptor Agonists and the Risk of Thyroid Cancer. Diabetes Care 2023;46:384–390Mayumi Endo, Irl B. Hirsch, Mara Y. Roth et al.|Diabetes Care|2023Cited by 5